Pathologie pp 288-300 | Cite as

Spongiöse Dystrophien und mitochondriale Enzephalopathien

  • W. Paulus

Zusammenfassung

Die Veränderungen reichen von feinsten, etwa Nukleolengröße entsprechenden Hohlräumen (wie bei frischen Ödemzuständen in der grauen Substanz) bis hin zu wabenförmigen Auflockerungen (wie beim Alpers-Syndrom).

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

Literatur

  1. 1.
    DiMauro S (ed) (1992) Mitochondrial encephalomyopathies (symposium). Brain Pathol 2: 111–162PubMedCrossRefGoogle Scholar
  2. 2.
    Jellinger K, Seitelberger F (1977) Spongy encephalopathies in infancy: spongy degeneration of eNS and progressive infantile poliodystrophy. In: Goldensohn ES, Appel SH (eds) Scientific approaches to clinical neurology. Lea & Febiger, Philadelphia, pp 363–386Google Scholar
  3. 3.
    Norenberg MD, Bruce-Gregorios J (1991) Nervous system manifestations of systemic disease. In: Davis RL, Robertson DM (eds) Textbook of neuropathology. Williams & Wilkins, Baltimore, pp 461–534Google Scholar
  4. 4.
    Altmann HW (1972) Glycogenhaltige Karyosphäriden in Gliakernen bei hepatogener Encephalopathie. Virchows Arch [B] 11: 263–267Google Scholar
  5. 5.
    Ballinger SW, Shoffner JM, Hedaya EV et al. (1992) Maternally transmitted diabetes and deafness associated with a 10.4 kb mitochondrial DNA deletion. Nature Genet 1: 11–15PubMedCrossRefGoogle Scholar
  6. 6.
    Bardosi A, Creutzfeldt W, DiMauro S et al. (1987) Myo-, neuro-, gastrointestinal encephalopathy (MNGIE syndrome) due to partial deficiency of cytochrome-c-oxidase. A new mitochondrial multisystem disorder. Acta Neuropathol 74: 248–258PubMedCrossRefGoogle Scholar
  7. 7.
    Berkovic SF, Carpenter S, Evans A et al. (1989) Myoclonus epilepsy and ragged-red fibres (MERRF). 1. A clinical, pathological, biochemical. magnetic resonance spectrographic and positron emission tomographic study. Brain 112: 1231–1260PubMedCrossRefGoogle Scholar
  8. 8.
    Butterworth RF (1992) Pathogenesis and treatment of portalsystemic encephalopathy: an update. Dig Dis Sci 37: 321–327PubMedCrossRefGoogle Scholar
  9. 9.
    Coo IFM de, Gabreëls FJM, Renier WO et al. (1991) Canavan disease: neuromorphological and biochemical analysis of a brain biopsy specimen. Clin Neuropathol 10: 73–78PubMedGoogle Scholar
  10. 10.
    Diemer NK, Klee J, Schröder H, Klinken L (1977) Gliäl and nerve cell changes in rats with porto-caval anastomosis. Acta Neuropathol 39: 59–68PubMedCrossRefGoogle Scholar
  11. 11.
    Erhslöh F (1958) Funikuläre Spinalerkrankung. In: Scholz W, Lubarsch O, Henke F, Rössle R. (Hrsg) Handbuch der speziellen pathologischen Anatomie und Histologie, Bd 13/2B. Springer, Berlin Göttingen Heidelberg, S 1526–1601Google Scholar
  12. 12.
    Erbslbh F (1958) Das Zentralnervensystem hei Leberkrankheiten. In: Scholz W, Lubarsch O, Henke F, Rössle R. (Hrsg) Handbuch der speziellen pathologischen Anatomie und Histologie, Bd 13/2B. Springer, Berlin Gottingen Heidelberg, S 1645–1698Google Scholar
  13. 13.
    Erven PMM van, Cillessen JPM, Eekhoff EMW et al. (1987) Leigh syndrome, a mitochondrial encephalo(myo)pathy. A review of the literature. Clin Neurol Neurosurg 89: 217–230PubMedCrossRefGoogle Scholar
  14. 14.
    Ferreiro JA, Robert MA, Townsend J, Vinters HV (1992) Neuropathologic findings after liver transplantation. Acta Neuropathol 84: 1–14PubMedCrossRefGoogle Scholar
  15. 15.
    Friede RL (1989) Developmental neuropathology. 2nd ed. Springer, Berlin Heidelberg New York TokyoCrossRefGoogle Scholar
  16. 16.
    Gambetti P, Mellman WJ, Gonatas NK (1969) Familial spongy degeneration of the central nervous system (Van-Bogaert-Bertrand disease). An ultrastructural study. Acta Neuropathol 12: 103–115PubMedCrossRefGoogle Scholar
  17. 17.
    Gascon GG, Ozand PT, Mahdi A et al. (1990) Infantile CNS spongy degeneration - 14 cases: clinical update. Neurology 40: 1876–1882PubMedGoogle Scholar
  18. 18.
    Giangaspero F, Dondi C, Scarani P, Zanetti G, Marchesini G (1985) Degeneration of the corticospinal tract following portosystemic shunt associated with spinal cord infarction. Virchows Arch [A] 406: 475–481CrossRefGoogle Scholar
  19. 19.
    Goto Y, Nonaka I, Horai S (1990) A mutation in the tRNALeu(UUR) gene associated with the MELAS suhgroup of mitochondrial encephalomyopathies. Nature 348: 651–653PubMedCrossRefGoogle Scholar
  20. 20.
    Goto Y, Horai S, Matsuoka T et al. (1992) Mitochondrial myopathy, encephalopathy, lactic acidosis, and stroke-like episodes. A correlative study of the clinical features and mitochondrial DNA mutation. Neurology 42: 545–550PubMedGoogle Scholar
  21. 21.
    Haltia M, Suomalainen A, Majander A, Somer H (1992) Disorders associated with multiple deletions of mitochondrial DNA. Brain Pathol 2: l33–139Google Scholar
  22. 22.
    Hammans SR, Sweeney MG, Brockington M, Morgan-Hughes JA, Harding AE (1991) Mitochondrial encephalopathies: molecular genetic diagnosis from blood samples. Lancet 337: 1311–1313PubMedCrossRefGoogle Scholar
  23. 23.
    Harding BN (1990) Progressive neuronal degeneration of childhood with liver disease (Alpers-Huttenlocher syndrome): a personal review. J Child Neurol 5: 273–287PubMedCrossRefGoogle Scholar
  24. 24.
    Hellenberg Hubar JLM van, Gabreels FJM, Ruitenbeek W et al. (1991) MELAS syndrome. Report of two patients, and comparison with data of 24 patients derived from the literature. Neuropediatrics 22: 10–14CrossRefGoogle Scholar
  25. 25.
    Kageyama Y, Ichikawa K, Fujioka A et al. (1991) An autopsy case of mitochondrial encephalomyopathy with prominent degeneration in olivo-ponto-cerebellar system. Acta Neuropathol 83: 99–103PubMedCrossRefGoogle Scholar
  26. 26.
    Kaul R, Casanova J, Johnson AB, Tang P, Matalon R (1991) Purification, characterization, and localization of aspartoacylase from bovine brain. J Neurochern 56: 129–135CrossRefGoogle Scholar
  27. 27.
    Kimura T, Budka H (1986) Glial fibrillary acidic protein and S- 100 protein in human hepatic encephalopathy: irnmunocytoche mical demonstration of dissociation of two glia-associated proteins. Acta Neuropathol 70: 17–21PubMedCrossRefGoogle Scholar
  28. 28.
    Lockwood AH (1989) Neurologic complications of renal disease. Neurol Clin 7: 617–627PubMedGoogle Scholar
  29. 29.
    Lombes A, Bonilla E, DiMauro S (1989) Mitochondrial encephalomyopathies. Rev Neurol 145: 671–689PubMedGoogle Scholar
  30. 30.
    Manuelidis EE, Rorke LB (1989) Transmission of Alper’s disease (chronic progressive encephalopathy) produces experimental Creutzfeldt-Jakob disease in hamsters. Neurology 39: 615–621PubMedGoogle Scholar
  31. 31.
    Marks HG, Caro PA, Wang Z et al. (1991) Use of computed tomography, magnetic resonance imaging, and localized IH magnetic resonance spectroscopy in Canavan’s disease. A case report. Ann Neurol 30: 106–110PubMedCrossRefGoogle Scholar
  32. 32.
    Masters CL, Richardson EP Jr (1978) Subacute spongiform encephalopathy (Creutzfeldt-Jakob disease). The nature and progression of spongiform change. Brain 101: 333–344PubMedCrossRefGoogle Scholar
  33. 33.
    Matalon R, Michals K, Sebesta D et al. (1988) Aspartoacylase deficiency and N-acetylaspartic aciduria in patients with Canavan disease. Am J Med Genet 29: 463–471PubMedCrossRefGoogle Scholar
  34. 34.
    Matalon R, Michals K, Gashkoff P, Kaul R (1992) Prenatal diagnosis of Canavan disease. J Inherited Metab Dis 15: 392–394PubMedCrossRefGoogle Scholar
  35. 35.
    McKelvie PA, Morley JB, Byrne E, Marzuki S (1991) Mitochondrial encephalomyopathies: a correlation between neuropathological findings and defects in mitochondrial DNA. J Neurol Sci 102:51–60PubMedCrossRefGoogle Scholar
  36. 36.
    McShane MA, Hammans SR, Sweeney M et al. (1991) Pearson syndrome and mitochondrial encephalomyopathy in a patient with deletion of mtDNA. Am J Hum Genet 48: 39–42PubMedGoogle Scholar
  37. 37.
    Mizusawa H, Ohkoshi N, Watanabe M, Kanazawa I (1991) Peripheral neuropathy of mitochondrial myopathies. Rev Neurol 147: 501–507PubMedGoogle Scholar
  38. 38.
    Mohrmann RL, Mah V, Vinters HV (1990) Neuropathologic findings after bone marrow transplantation: an autopsy study. Hum Pathol 21:630–639PubMedCrossRefGoogle Scholar
  39. 39.
    Montero CG, Martinez AJ (1986) Neuropathology of heart transplantation: 23 cases. Neurology 36: 1149–1154PubMedGoogle Scholar
  40. 40.
    Norenberg MD, Neary JT, Norenberg LOB, McCarthy M (1990) Ammonia induced decrease in glial fibrillary acidic protein in cultured astrocytes. J Neuropathol Exp Neurol 49: 399–405PubMedCrossRefGoogle Scholar
  41. 41.
    Ohama E, Ikuta F (1987) Involvement of choroid plexus in mitochondrial encephalomyopathy (MELAS). Acta Neuropathol 75: 1–7PubMedCrossRefGoogle Scholar
  42. 42.
    Ohama E, Ohara S, Ikuta F et al. (1987) Mitochondrial angiopathy in cerebral blood vessels of mitochondrial encephalomyopathy. Acta Neuropathol 74: 226–233PubMedCrossRefGoogle Scholar
  43. 43.
    Ohara S, Ohama E, Takahashi H et al. (1988) Alterations of oligodendrocytes and demyelination in the spinal cord of patients with mitochondrial encephalomyopathy. J Neurol Sci 86: 19–29PubMedCrossRefGoogle Scholar
  44. 44.
    Oldfors A, Fyhr IM, Holme E, Larsson NG, Tulinius M (1990) Neuropathology in Kearns-Sayre syndrome. Acta Neuropathol 80:541–546PubMedCrossRefGoogle Scholar
  45. 45.
    Paulus W, Peiffer J (1990) Intracerebral distribution of mitochondrial abnormalities in 21 cases of infantile spongy dystrophy. J Neurol Sci 95: 49–62PubMedCrossRefGoogle Scholar
  46. 46.
    Peiffer J, Kustermann-Kuhn B, Mortier W et al. (1988) Mitochondrial myopathies with necrotizing encephalopathy of the Leigh type. Pathol Res Pract 183: 706–716PubMedCrossRefGoogle Scholar
  47. 47.
    Reusche E, Seydel U (1993) Dialysis-associated encephalopathy: light and electron microscopic morphology and topography and evidence of aluminum by laser microprobe mass analysis. Acta Neuropathol 86: 249–258PubMedCrossRefGoogle Scholar
  48. 48.
    Scalabrino G, Monzio-Compagnoni B, Ferioli ME et al. (1990) Subacute combined degeneration and induction of ornithine decarboxylase in spinal cords of totally gastrectomized rats. Lab Invest 62: 297–304PubMedGoogle Scholar
  49. 49.
    Schachenmayr W (1987) Pankreatitis-assoziierte Hirnbefunde: gibt es eine pankreatische Encephalopathie? Verh Dtsch Ges Pathol 71: 280–283PubMedGoogle Scholar
  50. 50.
    Scholtz CL, Swash M, Gray A, Kogeorgos J, Marsh F (1987) Neurofibrillary neuronal degeneration in dialysis dementia: a feature of aluminium toxicity. Clin Neuropathol 6: 93–97PubMedGoogle Scholar
  51. 51.
    Shoffner JM, Lott MT, Lezza AMS et al. (1990) Myoclonic epilepsy and ragged-red fiber disease (MERRF) is associated with a mitochondrial DNA tRNALys, mutation. Cell 61: 931–937PubMedCrossRefGoogle Scholar
  52. 52.
    Sparaco M, Bonilla E, DiMauro S, Powers JM (1993) Neuropathology of mitochondrial encephalomyopathies due to mitochondrial DNA defects. J Neuropathol Exp Neurol 52: 1–10PubMedCrossRefGoogle Scholar
  53. 53.
    Takeda S, Wakabayashi K, Ohama E, Ikuta F (1988) Neuropathology of myoclonus epilepsy associated with ragged-red fibers (Fukuhara’s disease). Acta Neuropathol 75: 433–440PubMedCrossRefGoogle Scholar
  54. 54.
    Tatuch Y, Christodoulou J, Feigenbaum A et al. (1992) Heteroplasmic mtDNA mutation (T----G) at 8993 can cause Leigh disease when the percentage of abnormal mtDNA is high. Am J Hum Genet 50: 852–858PubMedGoogle Scholar
  55. 55.
    Watanabe A, Shiota T, Tsuji T (1992) Cerebral edema during hepatic encephalopathy in fulminant hepatic failure. J Med 23: 29–38PubMedGoogle Scholar
  56. 56.
    Winkelman MD, Ricanati ES (1986) Dialysis encephalopathy: neuropathological aspects. Hum Pathol 17: 823–833PubMedCrossRefGoogle Scholar
  57. 57.
    Yamamoto M, Clemens PR, Engel AG (1991) Mitochondrial DNA deletions in mitochondrial cytopathies: observations in 19 patients. Neurology 41: 1822–1828PubMedGoogle Scholar

Copyright information

© Springer-Verlag Berlin Heidelberg 1995

Authors and Affiliations

  • W. Paulus

There are no affiliations available

Personalised recommendations